Urogen Pharma (URGN)
(Delayed Data from NSDQ)
$16.39 USD
-0.27 (-1.62%)
Updated Jul 10, 2024 04:00 PM ET
After-Market: $16.40 +0.01 (0.06%) 4:22 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.84 | 3.57% |
Earnings Summary
For their last quarter, Urogen Pharma (URGN) reported earnings of -$0.97 per share, missing the Zacks Consensus Estimate of -$0.93 per share. This reflects a negative earnings surprise of 4.30%. Look out for URGN's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.84 per share, reflecting a year-over-year increase of 18.45%.
Earnings History
Price & Consensus
Zacks News for URGN
Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?
URGN: What are Zacks experts saying now?
Zacks Private Portfolio Services